- Home
- IMNN vs UGRO Comparison
IMNN vs UGRO Comparison
Compare IMNN & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- UGRO
- Stock Information
- Founded
- IMNN 1982
- UGRO 2014
- Country
- IMNN United States
- UGRO United States
- Employees
- IMNN N/A
- UGRO N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- UGRO Industrial Specialties
- Sector
- IMNN Health Care
- UGRO Consumer Discretionary
- Exchange
- IMNN Nasdaq
- UGRO Nasdaq
- Market Cap
- IMNN 12.1M
- UGRO 3.8M
- IPO Year
- IMNN 1985
- UGRO N/A
- Fundamental
- Price
- IMNN $0.50
- UGRO $0.34
- Analyst Decision
- IMNN Buy
- UGRO Strong Buy
- Analyst Count
- IMNN 2
- UGRO 1
- Target Price
- IMNN $14.00
- UGRO $3.00
- AVG Volume (30 Days)
- IMNN 1.5M
- UGRO 580.0K
- Earning Date
- IMNN 08-13-2025
- UGRO 07-22-2025
- Dividend Yield
- IMNN N/A
- UGRO N/A
- EPS Growth
- IMNN N/A
- UGRO N/A
- EPS
- IMNN N/A
- UGRO N/A
- Revenue
- IMNN N/A
- UGRO $59,985,138.00
- Revenue This Year
- IMNN N/A
- UGRO N/A
- Revenue Next Year
- IMNN N/A
- UGRO $31.25
- P/E Ratio
- IMNN N/A
- UGRO N/A
- Revenue Growth
- IMNN N/A
- UGRO N/A
- 52 Week Low
- IMNN $0.37
- UGRO $0.26
- 52 Week High
- IMNN $3.65
- UGRO $1.92
- Technical
- Relative Strength Index (RSI)
- IMNN 32.54
- UGRO 50.16
- Support Level
- IMNN $0.70
- UGRO $0.31
- Resistance Level
- IMNN $0.86
- UGRO $0.35
- Average True Range (ATR)
- IMNN 0.07
- UGRO 0.04
- MACD
- IMNN -0.03
- UGRO 0.01
- Stochastic Oscillator
- IMNN 1.23
- UGRO 38.88
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.